Micron Stock, November 2026: 13.3% Single-Session Decline With No Disclosed Catalyst
Micron closed at $689.15, down 13.3%, on the November 4, 2026 session, with no published report identifying the trigger; a halted $4.5 billion Taoyuan plant, CXMT's rising DRAM ambitions, and FY2026 capex of $30.71 billion define the contested backdrop.
- 최근 회계연도 설비투자
- $30.71B (FY2026)
- 전년 대비
- 93.7% · $15.86B → $30.71B
- 투자 / 매출
- 23% (FY2026, $133.19B)
- 최고 기록 기간
- $5.39B · 2025-11-27
Micron's shares closed at $689.15 on the November 4, 2026 session, shedding 13.3% — a move for which no published report reviewed by Slicast identifies a specific catalyst. The absence of a clear explanation is itself analytically significant: the company enters this period of market turbulence with a verifiable sold-out order book, $133.19 billion in FY2026 revenue, and a capital expenditure program that Slicast's compilation of SEC XBRL data places at the highest absolute level among the 14 chip companies in its peer universe. That the stock can trade this way against those fundamentals reflects the degree to which investors are discounting acknowledged risks against a competitive horizon that remains genuinely uncertain.
The two most consequential developments arriving in November reporting both represent headwinds. Micron's $4.5 billion Taoyuan factory construction has been halted by a labor dispute over profit-sharing, with Micron and the Taoyuan union reportedly scheduled to hold further talks on November 6. The significance of that stoppage extends beyond its immediate operational impact: the Taoyuan facility is part of a broader manufacturing build-out consuming capital at a striking pace. Slicast's data shows FY2026 capex reaching $30.71 billion — up 93.7% from $15.86 billion in FY2025, representing 23% of that fiscal year's $133.19 billion in revenue. Any prolonged halt compounds the financial exposure that this level of investment already implies.
Simultaneously, China's CXMT has been pressing its case on the technical front. The company reportedly told Pandaily that first samples of its 4F² DRAM architecture will ship by year-end, a direct answer to Micron's own published arguments against that approach. Micron's CTO confirmed to Nikkei Asia in October reporting that the company will not pursue 4F², a strategic decision that some analysts describe as a deliberate rejection of that approach. The debate matters because CXMT's stated ambition, flagged in November by analyst Dan Niles, is to capture 20% DRAM market share by 2028 — a threshold that, if reached, would materially reshape the competitive structure of the memory industry. Counterarguments exist: a StreetInsider piece cited a seven-point analysis arguing that CXMT's claims do not threaten Micron.
The fundamental picture that memory markets present to Micron remains supportive even as sentiment has shifted. The company disclosed in October that AI memory chips are sold out through 2026 and into 2028, a view broadly consistent with SK Hynix's separate confirmation that its own memory supply is fully booked through 2029. Apple, per November reporting, faces a $33 billion manufacturing-cost increase as RAM prices continue to rise, with Samsung, SK Hynix, and Micron all channeling capacity toward higher-margin server products over consumer demand. A $35 billion buyback program announced in October was not, on its own, sufficient to stabilize market nerves, per one contemporaneous report. Investment adviser Ross Gerber, however, cited multi-year supply agreements in arguing that the October decline was overdone, and Seeking Alpha's October analysis projected that HBM — which currently weighs on margins — would flip to a profit driver in 2027, a potential inflection that sits at the core of the medium-term bull case.
Micron has also been active in defining its product agenda. October and November reporting described a comprehensive technology roadmap: DDR6, LPDDR6, an HBM4 ramp-up, a next-generation 3D NAND exceeding 400 layers that doubles bit density, and an edge-inference memory product targeting 2028 mass production for AI robotics applications. The decision to skip a planned intermediate NAND generation was confirmed in October reporting.
The outlook is defined by genuine tension on both sides. The bull case is structural: AI infrastructure demand continues to outpace supply, Micron holds the top position by absolute capex among its chip peers in Slicast's universe, its AI memory order book extends well beyond the current fiscal year, and the HBM4 margin trajectory is improving. The bear case is not trivial: CXMT's acceleration in DRAM, however contested, is not dismissible; the Taoyuan labor halt introduces near-term execution risk into an already capital-intensive expansion; and the broader question raised in October by Simply Wall St — whether AI spending can sustain the velocity implied by Micron's FY2026 capital commitment — remains unanswered. Three signals warrant close attention: the outcome of the November 6 Taoyuan union talks and any timeline given for resuming construction; whether CXMT delivers its first 4F² samples by year-end, as it has indicated; and Micron's next reported HBM unit economics, which will be the clearest test of whether the 2027 margin-flip thesis is tracking on schedule.